Identification of a Potential Lead Structure for Designing New Antimicrobials to Treat Infections Caused by Staphylococcus epidermidis-Resistant Strains
- 128 Downloads
Bacterial infections are a significant cause of morbidity and mortality among critically ill patients. The increase of antibiotic resistance in bacteria from human microbiota—such as Staphylococcus epidermidis, an important nosocomial pathogen that affects immunocompromised patients or those with indwelling devices—increased the desire for new antibiotics. In this study we designed, synthesized, and determined the antimicrobial activity of 27 thieno[2,3-b]pyridines (1, 2, 2a–2m, 3, 3a–3m) derivatives against a drug-resistant clinical S. epidermidis strain. In addition, we performed a structure-activity relationship analysis using a molecular modeling approach, and discuss the drug absorption, distribution, metabolism, excretion, and toxicity profile and Lipinski’s “rule of five,” which are tools to assess the relationship between structures and drug-like properties of active compounds. Our results showed that compound 3b (5-(1H-tetrazol-5-yl)-4-(3`-methylphenylamino)thieno[2,3-b]pyridine) was as active as oxacillin and chloramphenicol but with lower theoretical toxicity risks and a better drug likeness and drug score potential than chloramphenicol. All molecular modeling and biological results reinforced the promising profile of 3b for further experimental investigation and development of new antibacterial drugs.
KeywordsOxacillin Drug Score Pyridine Derivative Meta Position Phenylamino
We thank the Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal Docente (CAPES), and Programa de Pós-Graduação da Universidade Federal Fluminense (UFF) for the financial support and H.C.C., P.S., and A.L.L. fellowships.
- 1.Ang JY, Ezike E, Asmar BI (2004) Antibacterial resistance. Symp Ser Soc Appl Microbiol 3:229–239Google Scholar
- 2.Bernardino AMR, Azevedo AR, Pinheiro LCS, Borges JC, Carvalho VL, Miranda MD, Meneses MDF, Nascimento M, Ferreira D, Rebello MA, Silva VAGG, Frugulhetti ICPP (2007) Synthesis and antiviral activity of new 4-(phenylamino)/4-[(methylpyridin-2-yl)amino]-1-phenyl-1H-pyrazolo[3, 4-b]pyridine-4-carboxylic acids derivatives. Med Chem Res 16:352–369CrossRefGoogle Scholar
- 3.Bernardino AMR, Castro HC, Frugulhetti ICPP, Loureiro NIV, Alexandre R, Azevedo AR, Pinheiro LCS, Souza TML, Giongo V, Passamani F, Magalhães UO, Albuquerque MG, Cabral LM, Rodrigues CR (2008) SAR of a series of anti-HSV-1acridone derivatives, and a rational acridone-based design of a new anti-HSV-1 3H-benzo[b]pyrazolo[3, 4-h]-1, 6-naphthyridine series. Bioorg Med Chem 16:313–321PubMedCrossRefGoogle Scholar
- 4.Bernardino AMR, Pinheiro LCS, Rodrigues CR, Loureiro NI, Castro HC, Lanfredi-Rangel A, Sabatini-Lopes J, Borges JC, Carvalho JM, Romeiro GA, Ferreira VF, Frugulhetti ICPP, Vannier-Santos MA (2006) Design, synthesis, SAR, and biological evaluation of new 4-(phenylamino)thieno[2, 3-b]pyridine derivatives. Bioorg Med Chem 14:5765PubMedCrossRefGoogle Scholar
- 8.Hansch C, Leo L (1995) Exploring QSAR. Fundamentals and applications in chemistry and biology. American Chemical Society, Washington, DCGoogle Scholar
- 15.Oliveira CGT, Miranda FF, Ferreira VF, Freitas CC, Carballido JM, Corrêa LCD (2001) Synthesis and antimicrobial evaluation of 3-hydrazino-naphthoquinones as analogs of lapachol. J Braz Chem Soc 12:339–345Google Scholar
- 17.Pinheiro LCS, Azevedo AR, Frugulhetti ICPP, Carneiro JL, de M, Souza TML, Ferreira VF, Bernardino AMR (2004) Synthesis and antiviral activity of new 4-(phenylamino)thieno[2, 3-b]pyridine derivatives. Heterocycl Commun 10:407–410Google Scholar